NCT04433156 2026-04-09VR-CAP in the First-line Treatment for Patients With Marginal Zone LymphomaHenan Cancer HospitalPhase 2 Completed26 enrolled
NCT07233720 2025-11-18Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone LymphomaHenan Cancer HospitalRecruiting30 enrolled